Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
About Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Investors & Backers
Foundation Medicine has received investment from 3 venture capital firms.
OrbiMed Advisors
Roche Venture Fund
Third Rock Ventures
Full portfolios: Roche Venture Fund portfolio, Third Rock Ventures portfolio
Frequently Asked Questions
What does Foundation Medicine do?
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Who invested in Foundation Medicine?
Foundation Medicine has received investment from OrbiMed Advisors, Roche Venture Fund, Third Rock Ventures. These venture capital firms and investors provide both capital and strategic support.
How much funding has Foundation Medicine raised?
Foundation Medicine has raised $456M in total funding, with their most recent round being a IPO. The company operates in the Biotech sector.
When was Foundation Medicine founded?
Foundation Medicine was founded in 2010 and is headquartered in Boston, Massachusetts.
What sector is Foundation Medicine in?
Foundation Medicine operates in the Biotech sector. Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for...
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Company Details
- Sector
- Biotech
- Headquarters
- Boston, Massachusetts
- Founded
- 2010
- Status
- Active
- Last Funding Stage
- IPO
- Total Funding
- $456M
